Results 271 to 280 of about 767,890 (335)
Ophthalmological manifestations in autoimmune diseases: Overcoming diagnostic and therapeutic challenges. [PDF]
El Kaouri I +6 more
europepmc +1 more source
The effects of magnesium supplementation in autoimmune rheumatic diseases
Motti Haimi +3 more
openalex +1 more source
Deletion of ASAH2 in intestinal epithelial cells induces the accumulation of ganglioside GD3 via regulating ST8SIA1. GD3 is identified as the glycolipid ligand for the inhibitory receptor Siglec‐E on macrophages. GD3/Siglec‐E ligation polarizes macrophages and promotes the proliferation of colonic ST2+ T regulatory cells via the induction of IL‐33. The
Zhishan Xu +11 more
wiley +1 more source
Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions. [PDF]
Ceasovschih A +12 more
europepmc +1 more source
Puerarin targets mitochondrial MIC19 in tumor‐infiltrating Tregs, impairing their immunosuppressive function and enhancing antitumor immunity. This study uncovers the metabolic dependency of tumor‐infiltrating Tregs and highlights a potential metabolic‐targeted immunotherapeutic strategy for liver cancer. Abstract Regulatory T cells (Tregs) are pivotal
Yu Li +10 more
wiley +1 more source
Global prevalence of autoimmune diseases in turner syndrome: a systematic review and meta-analysis. [PDF]
Hwang S +8 more
europepmc +1 more source
This study demonstrates that dual UCP2/IL‐17 blockade reprograms T‐cell metabolism to overcome PDAC immunosuppression. Genipin‐mediated UCP2 inhibition enhances CD8⁺ T‐cell IFN‐γ via IL‐12R/STAT4/mTOR signaling and mitochondrial OXPHOS. Combined IL‐17 depletion amplifies Tc1/Th1 responses, reduces MDSCs, and prolongs survival in PDAC models ...
Chuan‐Teng Liu +11 more
wiley +1 more source
Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions. [PDF]
Alsayb MA.
europepmc +1 more source

